PlainRecalls
FDA Drug Moderate Class II Terminated

Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-542-07.

Reported: July 31, 2019 Initiated: July 16, 2019 #D-1513-2019

Product Description

Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-542-07.

Reason for Recall

CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

Details

Units Affected
11472 bottles
Distribution
Nationwide in the USA.
Location
Cerkezkoy, N/A

Frequently Asked Questions

What product was recalled?
Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-542-07.. Recalled by Deva Holding AS - Cerkezkoy Subesi. Units affected: 11472 bottles.
Why was this product recalled?
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 31, 2019. Severity: Moderate. Recall number: D-1513-2019.